Dacima Software Inc. (Dacima), a leading innovator in EDC technology, is pleased to announce that ICON plc (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical devices industries, has selected Dacima to be on its global supplier list as a provider of EDC software.
Dacima Clinical Suite, is a 21 CFR Part 11 compliant, web-based EDC software platform, for electronically collecting and managing data for clinical and health research. With flexible and powerful design capabilities, Dacima Clinical Suite can be easily configured for different study design, including randomized clinical trials, observational study designs, patient registries, chart review studies, web surveys and meta-analysis. The software also includes an integrated IWRS (web randomization), drug management, electronic Patient Reported Outcomes (ePRO), eDiary, and coding modules (MedDRA and WHODrug). The software incorporates many advanced design capabilities, not available in other EDC software, that allows for the setup of sophisticated, advanced and user-friendly eCRFs through a web based designer module, without the need for computer programming expertise
In order to be added to ICON’s global supplier list “ICON conducted a comprehensive audit to evaluate Dacima’s compliance with 21 CFR Part 11, application lifecycle management and software validation processes” commented Dr. John Podoba, President and CEO of Dacima.
About Dacima Software Inc.
Dacima software is a leading innovator of Electronic Data Capture technology. Its Dacima Clinical Suite EDC platform is a web-based software application used by Clinical Research Organizations (CROs), pharmaceutical companies, medical device companies, biotechnology companies, governmental agencies, non-profit organization and academic researchers around the world. Dacima, a company based in Montreal, Canada, has more than 11 years experience in the development of EDC technology for the life sciences. More information about Dacima Software Inc. can be found at www.dacimasoftware.com.
About ICON PLC
ICON plc is a global provider of outsourced drug development services to the biopharma, medical device, government, biosimilar and generic organizations. They offer clinical, consulting and commercial services that range form trial design to full study executions. ICON employees approximately 13,100 employees and operates form 97 locations in 38 countries. Further information is available at www.iconplc.com.Like this article? Share it!